News

Pfizer and BioNTech Receive $2 Billion from U.S. Government for COVID-19 Vaccine

Pfizer and BioNTech Receive $2 Billion from U.S. Government for COVID-19 Vaccine

Pfizer and BioNTech will receive $2 billion from the U.S. government for 100 million doses of their coronavirus vaccine— if it is proven as safe for human consumption and effective in the prevention of the virus. The government also has the ability to acquire an additional 500 million doses of the drug going forward. As of yet, only preliminary research has been announced. In order to prove effective, the companies will have to conduct large-scale international trials. As a trusted clinical packaging provider and clinical supplies premium courier, as well as ancillary materials provider backed by a strong global network, Yourway can support clinical trials wherever they occur.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?